Catalogo dei prodotti della ricerca

BRAGAZZI, MARIA CONSIGLIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.447
EU - Europa 1.792
AS - Asia 682
SA - Sud America 36
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.407
IT - Italia 883
SG - Singapore 301
IE - Irlanda 268
IN - India 167
CN - Cina 155
SE - Svezia 121
FI - Finlandia 98
RU - Federazione Russa 83
DE - Germania 72
GB - Regno Unito 58
BG - Bulgaria 36
FR - Francia 36
ID - Indonesia 35
CA - Canada 32
NL - Olanda 30
UA - Ucraina 29
AT - Austria 23
BR - Brasile 21
RO - Romania 13
TG - Togo 11
AR - Argentina 9
CH - Svizzera 9
HK - Hong Kong 8
HR - Croazia 6
CZ - Repubblica Ceca 5
ES - Italia 5
MX - Messico 5
ZA - Sudafrica 5
BE - Belgio 4
EG - Egitto 4
KH - Cambogia 4
LT - Lituania 4
KE - Kenya 3
AU - Australia 2
BO - Bolivia 2
CL - Cile 2
GR - Grecia 2
HU - Ungheria 2
JP - Giappone 2
KZ - Kazakistan 2
PL - Polonia 2
TR - Turchia 2
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BJ - Benin 1
BZ - Belize 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
LI - Liechtenstein 1
MA - Marocco 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 5.987
Salva come PNG Salva come JPEG
Città #
Fairfield 617
Woodbridge 274
Dublin 265
Ashburn 237
Rome 234
Seattle 231
Chandler 206
Cambridge 190
Houston 189
Singapore 173
Wilmington 170
Princeton 100
Beijing 99
Ann Arbor 97
Santa Clara 71
Fremont 69
Plano 67
Helsinki 58
Dearborn 53
San Paolo di Civitate 48
Lawrence 47
Boston 43
San Diego 43
Milan 38
Millbury 36
Sofia 35
Jakarta 33
London 28
New York 26
Nuremberg 24
Des Moines 23
Moscow 23
Phoenix 21
Nanterre 20
Andover 18
Bologna 18
Naples 18
Ottawa 18
Norwalk 14
Piscataway 12
Southend 12
Council Bluffs 11
Lomé 11
Toronto 11
San Mateo 10
Falls Church 9
Federal 9
Florence 9
Redwood City 9
Boardman 8
Falkenstein 8
Los Angeles 8
Padova 8
Princeton Junction 8
San Nicola la Strada 8
Vienna 8
Bangalore 7
Bühl 7
Mannheim 7
Palermo 7
Catania 6
Guangzhou 6
Iesi 6
Jacksonville 6
Kunming 6
Livorno 6
Orem 6
São Paulo 6
Verona 6
Yubileyny 6
Frankfurt am Main 5
Genoa 5
Genova 5
Grossalmerode 5
Hong Kong 5
Mascalucia 5
Nanjing 5
Teolo 5
Zagreb 5
Beinasco 4
Bremen 4
Carmignano 4
Lappeenranta 4
Madrid 4
Mexico City 4
Phnom Penh 4
Pontedera 4
Sesto San Giovanni 4
Strasbourg 4
Venice 4
Zurich 4
Alpharetta 3
Amsterdam 3
Bolzano Vicentino 3
Caldwell 3
Colle Di Val D'elsa 3
Formigine 3
Hefei 3
Hostivice 3
Latina 3
Totale 4.341
Salva come PNG Salva come JPEG
Nome #
FXR modulators and cholestatic diseases | [Modulatori di FXR e patologie colestatiche] 270
Poliprotect vs omeprazole in the relief of heartburn, epigastric pain and burning in patients without erosive esophagitis and gastro-duodenal lesions. A randomized, controlled trial 222
Italian clinical practice guidelines on Cholangiocarcinoma – Part I: Classification, diagnosis and staging 156
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 140
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma 128
Profiles of cancer stem cell subpopulations in cholangiocarcinomas 121
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples 114
Transplantation of stem/progenitor cells isolated from human fetal biliary tree into two patients with advanced liver cirrhosis 114
Italian practical clinical guidelines on cholangiocarcinoma: Part II, treatment 104
547 CHOLANGIOCARCINOMA IN ITALY: A NATIONAL SURVEY ON DEMOGRAPHIC AND CLINICAL CHARACTERISTICS, DIAGNOSTIC MODALITIES AND TREATMENT 104
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA response score 103
Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images 102
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics 97
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 97
Intrahepatic cholangiocarcinoma: review and update 95
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines 90
Comprehensive characterization of cancer driver genes and mutations 86
Cholangiocytes: Cell transplantation 86
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas 86
Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage 85
Cholangiocarcinoma: Update and future perspectives 85
New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin 81
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors. 81
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers 80
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas 80
Cholangiocarcinoma: increasing burden of classifications 78
Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells 78
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context 76
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers 75
Polycystins play a key role in the modulation of cholangiocyte proliferation 74
Descriptive epidemiology of cholangiocarcinoma in Italy. 74
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma 72
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 70
Free episomal and integrated HBV DNA in HBsAg-negative patients with intrahepatic cholangiocarcinoma 70
Sensitivity of human intrahepatic cholangiocarcinoma subtypes to chemotherapeutics and molecular targeted agents: A study on primary cell cultures 69
Biliary insulin like growth factor-1 (IGF1) is a sensitive marker for the diagnosis of extrahepatic cholangiocarcinoma 69
Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition (EMT) by AMPK/Foxo3a pathway in human intrahepatic cholangiocarcinoma (CCA) 68
null 68
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 64
Erratum: The Immune Landscape of Cancer (Immunity (2018) 48(4) (812–830.e14), (S1074761318301213), (10.1016/j.immuni.2018.03.023)) 64
Human Leukocyte Antigen Polymorphisms in Italian Primary Biliary Cirrhosis: A Multicenter Study of 664 Patients and 1992 Healthy Controls 64
Estrogens stimulate the growth of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor (VEGF) 63
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis 63
Characterization of Cancer Stem Cells in Human Cholangiocarcinoma (CCA) subtypes 63
HUMAN CHOLANGIOCARCINOMA (CCA) AND CCA CANCER STEM CELLS (CSCS) ARE HIGHLY SENSITIVE TO THE ANTIPROLIFERATIVE EFFECTS OF PI3-KINASE INHIBITORS 62
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas 62
An international genome-wide meta-analysis of primary biliary cholangitis: novel risk loci and candidate drugs 62
TUMORIGENIC POTENTIAL OF CANCER STEM CELLS (CSCS) ISOLATED FROM HUMAN CHOLANGIOCARCINOMA (CCA) SUBTYPES IN CIRRHOTIC LIVER 61
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 59
Systematic Analysis of Splice-Site-Creating Mutations in Cancer 59
Estrogens stimulate the growth of human cholangiocarcinoma by activating the vascular endothelial growth factor (VEGF) system 57
Cholangiocarcinoma: increasing burden of classifications. 57
Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas 57
Intrahepatic cholangiocarcinom. Evolving strategies in management and treatment 56
VEGF plays a major role in mediating estrogens proliferative effects on human intrahepatic cholangiocarcinoma 56
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types 56
Biliary insulin like growth factor-1 (IGF1) is a sensitive marker for the diagnosis of extrahepatic cholangiocarcinoma 56
null 56
Cholangiocarcinoma: epidemiology and risk factors. 55
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 55
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types 55
null 54
null 53
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 51
null 51
Tumorigenic potential of cancer stem cells (CSCs) isolated from human cholangiocarcinoma (CCA) subtypes in cirrhotic microenvironment 51
null 50
Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor (VEGF) 49
547 CHOLANGIOCARCINOMA IN ITALY: A NATIONAL SURVEY ON DEMOGRAPHIC AND CLINICAL CHARACTERISTICS, DIAGNOSTIC MODALITIES AND TREATMNET 46
Inflammatory and neoplastic cholangiopathies [Colangiopatie infiammatorie e neoplastiche] 45
Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075)) 41
De morbo gallico omnia quae extant apud omnes medicos cuiuscunque nationis: the sixteenth-century collection of Luigi Luigini 41
Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033)) 40
Sensitivity of human cholangiocarcinoma (CCA) cells and CCA cancer stem cells (CSCs) to chemotherapeutics and molecular targeted agents 39
SARCOIDOSIS AND COELIAC DEASEAS: DO NOT FORGET THE ASSOTIATION ! 39
Evidence-based management of primary liver cancers: cholangiocarcinoma [Gestione dei tumori primitivi del fegato basata sull’evidenza: colangiocarcinoma] 35
The spanish influenza pandemic: a lesson from history 100 years after 1918 34
Insulin like growth factor-1 (IGF1) expression and its role in the diagnosis of extrahepatic cholangiocarcinoma. 33
null 33
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 31
null 30
Metformin arrests the proliferation, enhances apoptosis and down-regulates epithelial to mesenchymal transition (EMT) in human cholangiocarcinoma (CCA): a study on human primary cell cultures 27
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers 25
TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures 24
HELICOBACTER PYLORI IN IMMIGRANTS: A FOREIGN BACTRIUM? 22
New Insight into Epidemiology of Cholangicarcinoma 21
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily 20
null 17
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 17
OC.13.3: Metformin Inhibits Proliferation, Enhances Apoptosis and Down-Regulates Epithelial to Mesenchymal Transition (EMT) in Human Cholangiocarcinoma (CCA): A Study on Human Primary Cell Cultures 16
Role of the Gut-Liver axis in the pathobiology of cholangiopathies. Basic and clinical evidence 14
The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist 14
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer 14
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas 13
The FXR Agonist, Obeticholic Acid, Inhibits the Cancerogenic Potential of Primary Human Cholangiocarcinoma Cells: a Study on Primary Human Cell Cultures 13
TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: a study on human primary cell cultures 13
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients 12
Primary biliary cholangitis. Perception and expectation of illness 12
Obeticholic acid, a FXR agonist, inhibits the cancerogenic potential of primary human cholangiocarcinoma (CCA) cells cultures 11
The Immune Landscape of Cancer 10
Totale 6.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020327 0 0 0 0 0 0 0 0 119 101 67 40
2020/2021598 33 33 36 35 45 107 4 36 70 128 57 14
2021/2022878 44 36 95 37 107 41 21 107 66 49 117 158
2022/20231.123 175 159 39 64 59 89 32 62 334 31 28 51
2023/2024875 48 82 60 74 100 139 62 84 11 81 86 48
2024/2025870 41 42 82 90 180 111 162 114 48 0 0 0
Totale 6.318